Abbott Laboratories Reports Q1 Non-GAAP EPS of $1.15 and Revenue of $11.16B
Abbott Laboratories (ABT) reported Q1 Non-GAAP earnings per share of $1.15, which met expectations, and revenue of $11.16 billion, surpassing estimates by $160 million. The company's first-quarter sales rose 7.8% year-over-year and 3.7% on a comparable basis.
Tickers: $ABT